TY  - CHAP
M1  - Book, Section
TI  - Thyroid Disorders
A1  - Jonklaas, Jacqueline
A1  - Kane, Michael P.
A2  - DiPiro, Joseph T.
A2  - Talbert, Robert L.
A2  - Yee, Gary C.
A2  - Matzke, Gary R.
A2  - Wells, Barbara G.
A2  - Posey, L. Michael
Y1  - 2017
N1  - 
T2  - Pharmacotherapy: A Pathophysiologic Approach, 10e
AB  - Patient  Care  Process  for  the  Management  of  HyperthyroidismCollectPatient  characteristics  (e.g.,  age,  race,  sex,  pregnancy  status)Patient  history  (past  medical,  family,  social)  including  patient  signs  and  symptoms:  warm,  smooth,  moist  skin,  palpitations,  exophthalmos,  pretibial  myxedema  and  unusually  fine  hair;  anxiety,  tremor,  heat  intolerance,  tachycardia,  weight  loss,  and  menstrual  disturbances.  See  Clinical  Presentation  Box.Current  medications  (including  OTC  and  herbal  medication  use)Objective  data  Heart  rate,  blood  pressur  (BP),  weight,  and  body  mass  index  (BMI)Labs  (e.g.,  FT4,  TT3,  TSH,  thyroid-stimulating  antibodies;  serum  electrolytes,  Scr,  ALT  )Other  diagnostic  tests  when  indicated  (e.g.  thyroid  ultrasound,  RAI  uptake  scan)AssessCause  of  hyperthyroidism  (see  Table  75-3)Current  medications  that  may  contribute  to  or  worsen  hyperthyroidismCurrent  medications  that  may  interact  with  anti-thyroid  therapyAppropriateness  and  effectiveness  of  current  anti-thyroid  regimenPlan*Drug  therapy  regimen  including  specific  anti-thyroid  therapy,  dose,  and  duration  (see  Table  75-5)Monitoring  parameters  including  efficacy  (e.g.  resolution  of  signs  and  symptoms)  and  safety  (symptomatic  hypothyroidism,  adverse  effects  of  medications),  laboratory  tests  (TSH,  FT4,  TT3,  and  CBC),  and  timeframePatient  education  (e.g.  purpose  of  treatment,  dietary  and  lifestyle  modification,  drug  therapy)Implement*Provide  patient  education  regarding  all  elements  of  treatment  planUse  motivational  interviewing  and  coaching  strategies  to  maximize  adherenceSchedule  follow-upFollow-up:  Monitor  and  EvaluateResolution  of  signs  and  symptomsPresence  of  adverse  effectsPatient  adherence  to  treatment  plan  using  multiple  sources  of  information*Collaborate  with  patient,  caregivers,  and  other  health  professionals  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1157515610
ER  -